Research applications

MedDay, a biotechnology company centred on disorders of the nervous system and incubated at the Brain and Spine Institute – Institut du Cerveau - ICM, announced today that the main criterion of its pivotal clinical trial MS-SPI was attained. The...

MedDay is a French biotech company in the treatment of neuro-metabolic diseases. Founded in 2011 by Frédéric Sedel and Guillaume Brion, MedDay relies on the work of Dr Frédéric Sedel, a neuroscientist at La Pitié Salpêtrière Hospital (Paris), who has...